Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy P Martens

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The Heart Surgery Forum|January 12, 2008
Patient-specific characteristics determine success of surgical atrial fibrillation ablation in patients with persistent atrial fibrillationKimberly N Hong, Mark J Russo, Mathew R Williams, et al.
The Journal of Biological Chemistry|September 21, 2005
Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemiaGuosheng Xiang, Tetsunori Seki, Michael D Schuster, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 25, 2006
Adult-age donors offer acceptable long-term survival to pediatric heart transplant recipients: an analysis of the United Network of Organ Sharing databaseMark J Russo, Ryan R Davies, Robert A Sorabella, et al.
Canadian Journal of Physiology and Pharmacology|September 2, 2008
Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptorJuan C Osorio, Faisal H Cheema, Timothy P Martens, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2011
Composite scaffold provides a cell delivery platform for cardiovascular repairAmandine F G Godier-Furnémont, Timothy P Martens, Michael S Koeckert, et al.
Cell Transplantation|June 30, 2009
Percutaneous cell delivery into the heart using hydrogels polymerizing in situTimothy P Martens, Amandine F G Godier, Jonathan J Parks, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 21, 2005
Effect of diabetes on short- and long-term outcomes after left ventricular assist device implantationVeli K Topkara, Nicholas C Dang, Timothy P Martens, et al.
The Annals of Thoracic Surgery|February 24, 2009
Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosageHirotsugu Hamamoto, Joseph H Gorman, Liam P Ryan, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 27, 2007
Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devicesAllison R Schulman, Timothy P Martens, Paul J Christos, et al.
Circulation|September 16, 2009
Mesenchymal cell transplantation and myocardial remodeling after myocardial infarctionJennifer A Dixon, Robert C Gorman, Robert E Stroud, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Heart Surgery Forum|January 12, 2008
Patient-specific characteristics determine success of surgical atrial fibrillation ablation in patients with persistent atrial fibrillationKimberly N Hong, Mark J Russo, Mathew R Williams, et al.
The Journal of Biological Chemistry|September 21, 2005
Catalytic degradation of vitamin D up-regulated protein 1 mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemiaGuosheng Xiang, Tetsunori Seki, Michael D Schuster, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 25, 2006
Adult-age donors offer acceptable long-term survival to pediatric heart transplant recipients: an analysis of the United Network of Organ Sharing databaseMark J Russo, Ryan R Davies, Robert A Sorabella, et al.
Canadian Journal of Physiology and Pharmacology|September 2, 2008
Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptorJuan C Osorio, Faisal H Cheema, Timothy P Martens, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 22, 2011
Composite scaffold provides a cell delivery platform for cardiovascular repairAmandine F G Godier-Furnémont, Timothy P Martens, Michael S Koeckert, et al.
Cell Transplantation|June 30, 2009
Percutaneous cell delivery into the heart using hydrogels polymerizing in situTimothy P Martens, Amandine F G Godier, Jonathan J Parks, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 21, 2005
Effect of diabetes on short- and long-term outcomes after left ventricular assist device implantationVeli K Topkara, Nicholas C Dang, Timothy P Martens, et al.
The Annals of Thoracic Surgery|February 24, 2009
Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosageHirotsugu Hamamoto, Joseph H Gorman, Liam P Ryan, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 27, 2007
Comparisons of infection complications between continuous flow and pulsatile flow left ventricular assist devicesAllison R Schulman, Timothy P Martens, Paul J Christos, et al.
Circulation|September 16, 2009
Mesenchymal cell transplantation and myocardial remodeling after myocardial infarctionJennifer A Dixon, Robert C Gorman, Robert E Stroud, et al.
Pageof 5